One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1016/j.annonc.2023.09.2094
Copy DOI Journal: Annals of Oncology |  Publication Date: Oct 1, 2023 |
Affiliation: Nanjing University of Chinese Medicine, BeiGene (China), Zhejiang University, Fudan University Shanghai Cancer Center, Liaoning Cancer Hospital & Institute, Shanghai East Hospital, Zhejiang Cancer Hospital, Huazhong University of Science and Technology, Second Affiliated Hospital of Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Hubei Cancer Hospital, First Affiliated Hospital of Nanchang University, Nanfang Hospital948P Phase (Ph) I/II study of sitravatinib (Sitra) alone or with tislelizumab (TIS) in advanced hepatocellular carcinoma (HCC) and gastric/gastroesophageal junction cancer (GC/GEJC)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
